Discover who we are
Learn more about our non-profit foundation
Discover our therapeutic areas, where we continuously invest to innovate
Ipsen is specialized in Oncology. Explore our activities
Ipsen is one of the global leaders in Neuroscience. Explore our activities
Ipsen is active in the rare diseases field
Explore our activities
Ipsen has a strong expertise in Consumer Healthcare. Explore our activities
Discover how we strive to launch at least one new drug or meaningful indication every year
We are dedicated to improving the lives of patients. Discover their patient stories
Information on clinical trials in an informative and transparent manner
Learn more about patient stories
Welcome to our dedicated section for investors
Read all the publications of the financial results for Ipsen Group
Check the dates of all events organized by Ipsen Group
Discover all the trending news of Ipsen group
Find all the latest Ipsen Group press releases.
Join our team!
Learn more about how we help every employee realize their full potential
Check our initiatives to make Ipsen the best working environment for all
To register for the webcast, please Click here.
Ipsen – Investor Day 2019
Standby statement on lanreotide generic
Ipsen – 2019 First Quarter results – April 24, 2019
Ipsen completes acquisition of Clementia Pharmaceuticals
Ipsen is present at ESGE Days with an educational symposium and two oral presentations
© Ipsen Group 2019
You are now leaving the Ipsen Group website
You are now leaving the Ipsen Group section. If you would like to visit an affiliate section, please click Continue. The information provided on this section may not necessarily be applicable to the Ipsen Group.